Pterygium

Non-Surgical Solution

XP37 offers a non-invasive alternative to surgery, reducing the risk of complications and the need for postoperative care.

Addressing Root Causes

Unlike traditional treatments that may only address symptoms, XP37 tackles the underlying mechanisms of pterygium by stopping abnormal blood vessel growth.

Recurrence Risk

Traditional treatments, such as surgery, often face the challenge of pterygium recurrence, whereas XP37 can enhance overall patient well-being and quality of life by minimizing the need for repeated interventions.

10.2% of people in the world have ptergyium

WHAT IS PTERYGIUM?

Pterygium is an ocular surface disease characterized mainly by a wing-shaped growth of tissue. This raised, fleshy growth is rich in blood vessels and begins in the conjunctiva, the transparent membrane covering the white part of the eye and gradually spreading over the adjacent cornea. A pterygium can range from a transparent area with a few blood vessels to a thick opaque growth that can obstruct vision. They can occur in one or both eyes. Pterygium often starts as a small, painless area of raised tissue on the white of the eye. Initially, it might not cause any symptoms or discomfort. However, when inflamed, one may experience symptoms such as redness, irritation, foreign body sensation, and blurred vision. Extended exposure to ultraviolet (UV) light and environmental factors such as dust, wind, and dry climates are believed to contribute to its development.

Do you have small eyes?

Pterygium may be associated with having a shorter axial length in the eyes (small eyes).

Do you live near the equator?

Pterygium is more prevalent in people living closer to the equator due to increased exposure to UV radiation.

COMPLICATIONS OF PTERYGIUM

As pterygium progresses, it quietly disrupts your daily life, starting with a persistent sensation of something in your eye and potential visual disturbances that become increasingly bothersome. In advanced stages, pterygium can induce significant visual impairment, complicating everyday tasks and diminishing overall quality of life.Moreover, in some cases, pterygium can scar the cornea, leading to severe damage and, ultimately, blindness if left untreated. Therefore, prompt attention and appropriate management are crucial to mitigate the impact of pterygium on vision and quality of life.

OUR ONGOING RESEARCH

Pterygium, a common eye condition, can cause significant discomfort and visual impairment. Traditional treatments, including surgery, often have drawbacks such as recurrence and post-operative complications, making pterygium management challenging and impacting patients' quality of life.

XP37 eye drops provide an innovative solution for managing pterygium. This treatment targets the anterior segment of the eye, blocking angiogenesis—the formation of new blood vessels—crucial in pterygium progression. By inhibiting this process, XP37 reduces the growth of abnormal blood vessels that extend over the cornea. This action alleviates inflammation and halts the progression of the growth, addressing the root cause rather than just the symptoms.

XP37 eye drops present a non-surgical, effective treatment option for pterygium, targeting its underlying mechanisms. This promising therapy offers hope for better management, improving patients' quality of life and minimizing the need for invasive procedures.

1. Shahraki T, Arabi A, Feizi S. Pterygium: an update on pathophysiology, clinical features, and management. Therapeutic Advances in Ophthalmology. 2021 May; 13:25158414211020152. 2. Pterygium. Available at: https://assileye.com/eye-care/pterygium. Last accessed on: May 22, 2024. 3. Zhang LM, Lu Y, Gong L. Pterygium Is Related to Short Axial Length. Cornea. 2020 Feb;39(2):140-145. 4. Fekadu SA, Assem AS, Adimassu NF. Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019. PLoS One. 2020 Sep 3;15(9):e0237891. 5. Pterygium. Available at- https://www.webmd.com/eye-health/pterygium-surfers-eye. Last accessed on: May 22, 2024. 6. Data on file.

PREVELANCE

A pterygium can range from a transparent area with a few blood vessels to a thick opaque growth that can obstruct vision. They can occur in one or both eyes2. Pterygium often starts as a small, painless area of raised tissue on the white of the eye. Initially, it might not cause any symptoms or discomfort. However, when inflamed, one may experience symptoms such as redness, irritation, foreign body sensation, and blurred vision. Extended exposure to ultraviolet (UV) light and environmental factors such as dust, wind, and dry climates are believed to contribute to its development.

Pterygium is a common ocular condition with a global prevalence of up to 33%, potentially affecting around 200 million people worldwide.